Health and Medicine

The European Burns Association was founded in 1981 by leading burn specialists in Europe. To encourage co-operation in the field of burn care throughout the continent. The EBA serves as a forum through which medical specialists, researchers, professions allied to medicine (PAM) and other workers come in contact to discuss aspects of burn treatment and research. In this way, expertise and knowledge are spread throughout the countries of Europe. And has been established as a non-profit making organisation for the benefit of the public, to promote burn prevention, to study the prevention of burn injury and all other aspects of…

Join us at the 27th Asia-Pacific League of Associations for Rheumatology (APLAR) Congress, where innovation, collaboration, and cultural connection will come together to shape the future of rheumatology. Set in the dynamic city of Fukuoka, APLAR 2025 welcomes over 3,000+ delegates from across the region and beyond. With the theme “Go Beyond with Harmony,” this year’s Congress invites you to explore new frontiers in patient care, scientific discovery, and professional growth. What to Expect: - 250+ scientific sessions led by global experts - Hands-on workshops and in-depth clinical courses - Opportunities for virtual participation and on-demand access - A strong…

With clinical momentum from Eli Lilly's lipidated brain shuttle siRNAs, Alnylam Pharmaceuticals' ALN-APP siRNA, Wave's Phase 1b/2a positive SELECT-HD data, 170+ biotech and 30+ pharma active in the field, and a surge of novel approaches, the oligonucleotide field shows no signs of slowing down. The 5th Oligonucleotides for CNS Summit unites a select group of industry-leading biologists, chemists, C-level executives, platform tech experts, DMPK and clinical pharmacologists, all tackling the unique challenges of CNS delivered ASOs, siRNAs, miRNAs and saRNAs. This August, hear from Alnylam Pharmaceuticals, Denali Therapeutics, Genentech, FDA, Novo Nordisk, Regeneron, Servier, Stoke Therapeutics, Ultragenyx Pharmaceutical and more,…

As the regulatory landscape continues to evolve, 2025 is a pivotal year for legal leaders in biopharma. The 6th In-House Impact: Biopharma Summit is your exclusive opportunity to unite with top legal minds from Takeda, Kura Oncology, Neurocrine Biosciences, and more to tackle today's most pressing challenges-tariffs, financing, M and A strategy, and beyond. Tailored for General Counsels and Chief Legal Officers at drug development companies, this intimate, peer-led summit empowers you to elevate legal as a business-critical function. Learn how in-house teams are adapting to economic volatility, harnessing new legal tech, and navigating cross-functional leadership demands, all while building…

We would like to solicit your gracious presence as a speaker at the “International Conference on Precision Medicine 2025” during 25-26 August, 2025 in London, Uk.

The scientific program will consist of state-of-the-art lectures, discussions, debates, and poster presentations. International keynote speakers will give lectures on various timely topics, including, for example, "Artificial Intelligence in Communication Disorders." IALP is the International Association of Communication Sciences and Disorders. It is a non-profit worldwide organization of professionals and scientists in communication, voice, speech language pathology, audiology and swallowing. The present conference aims to share a vision of developing an international network that, in turn, facilitates the use of innovative clinical and research methods and knowledge to better support practices of clinical management. Attending this conference in Malta is…

Scripps Cancer Center’s 2025 Oncology Update is a dynamic one-day conference designed to provide physicians and advanced practice providers with a comprehensive overview of the latest advancements in the treatment of lung, pancreatic, colorectal, and breast cancers. Led by a multidisciplinary team of expert medical oncologists, radiation oncologists, and surgeons, the program will highlight cutting-edge clinical data and practice-changing insights from recently published studies and major national conference presentations. Through a combination of interactive case-based discussions and engaging didactic lectures, participants will gain valuable insights into managing complex clinical scenarios and translating evidence-based knowledge into real-world practice. Attendees will leave…

This course offers targeted antimicrobial pharmacology education in which participants gain practical insights relevant to various practice settings. Using case-based presentation and in-depth discussions, subject matter experts cover topics including, pharmacokinetics, mechanism of action, dosing, and spectrum for approved and pipeline therapies. Real-life scenarios including drug interactions in tuberculosis and HIV are explored, and cutting-edge techniques like beta-lactam therapeutic drug monitoring are reviewed. Expert panels debate contemporary infection management. Additionally, this course provides valuable insights into individualized medicine principles. Upon completion of this activity, participants should be able to: -Evaluate new antimicrobial therapies for effective integration into clinical practice -Recognize…

This program will provide the cardiologist and electrophysiologist with an overview of all aspects of cardiovascular electrophysiology. Experts in each field will give in-depth didactics on state-of-the-art subjects in electrophysiology and device therapy. This program is designed specifically to ensure that graduating electrophysiology fellows are apprised of the key practical elements for arrhythmia and device management. The program design is also aimed at providing thorough preparation for electrophysiology boards or recertification. In-depth updates on the latest knowledge and advances in electrophysiology are also integrated into the course for the practicing electrophysiologist wishing to review and update. The full spectrum of…

This meeting centers on a true interdisciplinary approach to wound care, featuring insights from leading experts and case-based studies that highlight innovative treatment methods. It emphasizes both in-center and out-of-center healing strategies, encourages active audience participation and interaction with national wound care professionals, and promotes better information sharing to improve patient care. Networking opportunities through engaging social events are also a key focus. Our MISSION is to provide the highest quality continuing medical education experience to all clinicians who care for patients with chronic wounds and from this, improve patient outcomes by maintaining constant focus on the most modern and…

The external landscape for biopharma continues to shift as demand to protect budgets increases with uncertainty around tariffs, and companies have greater responsibility to manage a surplus in excess space. Despite these changes, scientific operations continue to progress, as evidenced by Novartis recent commitment to a $23 billion investment into new US manufacturing sites and Eli Lilly and Co's plans for four new sites. Standing as the backbone of scientific support, lab operations professionals are relied upon to manage the lab with the utmost efficiency, retain a compliant working environment, optimize resources, and wear as many hats as possible to…

As dual-payload and novel-payload ADCs fuel the next wave of innovation in the ADC space, the spotlight is shifting to the chemistry behind these advancements. With the need for strategies to overcome payload hydrophobicity, achieve optimal stability profiles, and reduce aggregation, linker and conjugation strategies have become crucial levers for unlocking improved therapeutic windows. Returning to Boston this August, the 3rd ADC Linker and Conjugation Summit is the only meeting fully dedicated to the chemistry that underpins ADC success. Join 80+ experts from AstraZeneca, Pfizer, Sutro Biopharma, Glykos, Catena Biosciences, Tubulis, and more for three days of focused insights and…

The pulmonary fibrosis field is entering a pivotal moment. Boehringer Ingelheim’s positive Phase 3 trials for nerandomilast, poised to be the first new approval in over a decade, have injected long-awaited momentum into the space. PureTech Health, Endeavor BioMedicines, Insilico Medicine, Bristol Myers Squibb, and United Therapeutics are rapidly advancing through mid- to late-stage trials, signaling a renewed era of therapeutic possibility. Yet 2025 has also brought setbacks, including Pliant’s discontinuation of the BEACON-IPF study for bexotegrast due to safety concerns, underscoring the complexity of treating this disease. If ever there was a year to invest in this space, it’s…

Join a global community of thought leaders and innovators shaping the future of bioprocessing. Dive into cutting-edge research, share insights with industry experts, and tackle the challenges of bioprocess R&D, scale-up, quality, and analytics. The Summit offers: Main Conference Sessions with actionable insights In-Depth Training Seminars led by industry pioneers An Engaging Exhibit Hall showcasing the latest technologies Networking Opportunities to connect with peers and experts Dedicated Programming on AI and machine learning in bioprocessing, Cell Culture, Purification and Cell & Gene Therapy, and More Elevate your expertise, expand your network, and drive innovation forward. Be part of the conversations…

Cambridge Healthtech Institute is proud to present the 17th Annual Next Generation Dx Summit which will take place at the Capital Hilton in Washington, D.C. on August 18-20, 2025. The Next Generation Dx Summit is the nexus for international thought leaders to discuss diagnostic advancement and technology innovation. This year’s event provides a valuable window on the state-of-the art, forecasting and future trends in point-of-care and decentralized testing, infectious disease, liquid biopsy, multi-cancer early detection, reimbursement, regulation, and companion diagnostics to improve standard of care in medicine. This must-attend Summit offers incomparable networking and complete coverage of the most timely…

COURSE DESCRIPTION Well-known experts in each field will give in-depth, engaging lectures on state-of-the-art subjects in cardiovascular medicine. Each lecture will be followed by a question and answer session with an audience response system. Although this course is designed specifically to prepare the cardiovascular specialist for the cardiovascular boards, it will also provide the practicing cardiologist or internist with an update on the latest knowledge and advances in cardiovascular medicine. WHAT MAKES OUR COURSE DIFFERENT -Access to the course content through the 2026 ABIM MOC examination dates -Electronic course syllabus INTENDED AUDIENCE This course is intended for cardiologists, cardiovascular fellows,…

This course will be focused on heart failure seen in daily clinical practice. The program will be primarily case based with a few supplemental lectures covering the bread and butter for heart failure, novel therapies, hospital readmission and advanced heart failure. Save the date to spend a 1.5 days with faculty for an update in heart failure management and enjoying the land of 10,000 lakes. Course Objectives - Recognize the clinical syndrome of heart failure and who is at risk - Describe typical diagnostic testing essential for diagnosis and management of heart failure - Describe how to apply appropriate pharmacologic…

Learn best practices and effective strategies to address mental health concerns with your patients. Mental health is the most widespread issue across primary care. The Psych Congress Primary Care online events were designed to equip primary care professionals to better treat mental health cases. This is your opportunity to learn from mental health's leading minds with our world-renowned faculty lineup. Access this educational opportunity conveniently online from the comfort of your own home or office. Instagram: https://go.evvnt.com/2881525-2?pid=154 Price: Free: USD 0.00 Speakers: Brittany B. Albright, MD, MPH, W. Clay Jackson, MD, DipTh Time: 08:00 to 17:30

This course will provide evidence-based strategies to address frequently encountered medically unexplained conditions. We will begin with a thorough discussion of the pathophysiological process of central sensitization; this will be followed by lectures focusing on specific medically unexplained conditions and symptoms. Each topic will utilize didactic sessions, case vignettes, clinical pearls, helpful tips, and formal Q/A sessions. Breakfast and Break with the Experts will also be provided to allow for additional discussion. Furthermore, this course will include an optional afternoon session focusing on burnout, wellness, resilience, and mindfulness. Optional Workshop- Burnout, Well-Being, and Resiliency: Tips to Care for You and…

As we mark 15 years of the Amputation Prevention Symposium (AMP), we look ahead to the next 15 years with renewed focus and an unwavering mission: saving limbs and saving lives. AMP continues to push the boundaries of chronic limb-threatening ischemia (CLTI) treatment, delivering a multidisciplinary platform where innovation meets advocacy. Looking forward, AMP is dedicated to advancing CLTI care by embracing groundbreaking technologies, offering hands-on learning opportunities, and fostering collaboration among diverse voices in the field. From immersive live cases and workshops to forward-thinking discussions on patient impact, AMP is the forum where emerging leaders and seasoned experts shape…